Literature DB >> 4073808

The role of fibreoptic bronchoscopy in the management of respiratory burns.

W C Tan, S T Lee, C N Lee, S Wong.   

Abstract

We found that fibreoptic bronchoscopy was a useful, simple, safe and accurate method in the diagnosis of inhalation injury, determining the type, the site and the extent of damage sustained. The most common mucosal damage was erythema and oedema of the supraglottic and glottic tissues, though in a few cases more severe and extensive injury was seen. Death seemed to be determined largely by the extent of skin burn but since there did not appear to be a close relationship between the severity of skin burn and the presence of inhalation burn, we suggest that the two types of injuries be evaluated separately. The main therapeutic role lies in the assessment and anticipation of imminent upper airway obstruction caused by oedema of the supraglottic tissues and the glottis. Endotracheal intubation could then be carried out promptly. Changes in clinical features and laboratory results were too slow to be of use in the prediction of upper airway obstruction, but could be indirect indicators of lower and peripheral airway injury.

Entities:  

Mesh:

Year:  1985        PMID: 4073808

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

Review 1.  Smoke inhalation: diagnosis and treatment.

Authors:  W R Clark
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

Review 2.  Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol.

Authors:  F X Sundram
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

3.  Treatment of burns in the first 24 hours: simple and practical guide by answering 10 questions in a step-by-step form.

Authors:  Ziyad Alharbi; Andrzej Piatkowski; Rolf Dembinski; Sven Reckort; Gerrit Grieb; Jens Kauczok; Norbert Pallua
Journal:  World J Emerg Surg       Date:  2012-05-14       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.